TRIM29 and neoplasm: Additionally, the patients with TRIM29-positive tumors showed significantly reduced recurrence-free survival compared to patients with TRIM29-negative tumors (TRIM29-positive tumor: recurrence-free survival of 10.8 months, TRIM29-negative tumor: recurrence-free survival of 17.1 months, P = 0.008, Figure 2(b)).